Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya31169Editorial articleПередовая статьяReview ArticleCarbohydrate metabolic disturbances and obstructive sleep apnea syndromeНарушения углеводного обмена и синдром обструктивного апноэ во снеOleĭnikovV ÉОлейниковВ Эoleynikoff@sura.ruSergatskaiaN VСергацкаяН ВМедицинский институт Пензенского государственного университета151020128410VOL 84, NO10 (2012)ТОМ 84, №10 (2012)11311810042020Copyright ©; 2012, Consilium MedicumCopyright ©; 2012, ООО "Консилиум Медикум"2012Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/31169

The paper analyzes an association between obstructive sleep apnea syndrome (OSAS) and carbohydrate metabolic disturbances. It presents the data of clinical trials that consider OSAS as a risk factor of type 2 diabetes mellitus (T2DM). The most important factors influencing the progression of carbohydrate metabolic disturbances in patients with OSAS are analyzed. Whether OSAS can be corrected as a modifiable risk factor in patients with T2DM is considered.

Аннотация. Анализируется взаимосвязь синдрома обструктивного апноэ во сне (СОАС) и нарушений углеводного обмена. Представлены данные клинических исследований, в которых СОАС рассматривается как фактор риска развития сахарного диабета 2-го типа (СД2). Приведен анализ наиболее значимых факторов, влияющих на прогрессирование нарушений углеводного обмена у пациентов с СОАС. Рассматривается возможность коррекции СОАС у больных СД2 в качестве модифицируемого фактора риска.

obstructive sleep apnea syndrometype 2 diabetes mellitusinsulin resistanceobesityglycemiaсиндром обструктивного апноэ во снесахарный диабет 2-го типаинсулинорезистентностьожирениегликемияРунихин А.Ю., Новикова Ю.В. Современные аспекты патогенеза и лечения сахарного диабета 2 типа. Рус мед журн 2007; 27: 2060-2065.Resnick H.E., Redline S., Shahar E. et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003; 26: 702-709.Бузунов Р.В. Синдром обструктивного апноэ сна в сочетании с ожирением: особенности патогенеза, диагностики и лечения: Дис. ... д-ра мед. наук. М 2003; 208.Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respirat Critical Care Med 2002; 165 (9): 1217-1239.Manser R.M., Rochford P., Pierce R.J. et al. Impact for defining hypopneas in the Panea-Hypopnea Index. Chest 2001; 120: 909-914.Knutson K.L., Spiegel K., Penev P., Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11 (3): 163-178.Marin J.M., Carrizo S.J., Vicente E. et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.Einhorn D., Stewart D.A., Erman M.K. et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007; 13: 355-362.Marshall N., Keith K., Wong M. et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton study? J Clin Sleep Med 2009; 5 (1): 15-20.Roncksley P.E., Hemmelgarn B.R., Heitman S.J. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009; 64: 834-839.West S.D., Nicoll D.J., Wallace T.M. et al. Obstructive sleep apnea in men with type 2 diabetes: a double blind randomized controlled trial of the effects of CPAP on HbA1c and insulin resistance [abstract]. Paper presented at: the American Thoracic Society Meeting; May 19-24, 2006; San Diego, CA.Foster G.E., Kuna S.T., Sanders M.H. et al. Sleep apnea in obese adults with type 2 diabetes: baseline results from sleep AHEAD study [abstract]. Sleep 2005; 25: 066.Tsai W.H. Obstructive sleep apnea is associated with diabetes in sleepy subjects. Thorax 2009; 64 (10): 834-839.Reichmuth K.J., Austin D., Skatrud J.B. et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172: 1590-1598.Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.Young T., Palta M., Dempsey J. et al. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328 (17): 1230-1235.Bixler E.O., Vgontzas A.N., Lin H.-M. et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Critical Care Med 2001; 163 (3.1): 608-613.Redline S., Kump K., Tishler P.V. et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Critical Care Med 1994; 149 (3.1): 722-726.Newman A.B., Nieto F.J., Guidry U. et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 1995; 154 (1): 50-59.Young T., Shahar E., Nieto F.J. et al. Predictors of sleepdisordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162 (8): 893-900.Bixler E.O., Vgontzas A.N., Ten Have T. et al. Effects of age on sleep apnea in men. Prevalence and severity. Am J Respir Critical Care Med 1998; 157 (1): 144-148.Duran J., Esnaola S., Rubio R., Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Critical Care Med 2001; 163 (3.1): 685-689.Redline S., Tishler P.V., Hans M.G. et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Critical Care Med 1997; 155(1): 186-192.Surani S., Aguillar R., Komari V. et al. Influence of Hispanic ethnicity in prevalence of diabetes mellitus on sleep apnea and relationship to sleep phase. Postgraduate Med 2009; 121 (15): 108-112.Punjabi N.M., Sorkin J.D., Katzel L.I. et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Critical Care Med 2002; 165 (5): 677-682.Guilleminault C., Bassiri A., Caskadon M.A. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and upper airway resistance syndrome. In: Kryger M.H., Roth T., Dement W.C. (eds) Principles and Practice of Sleep Medicine, 2nd ed. Philadelphia: Elsevier Saunders 2005: 1043-1052.Bliwise D.L., Feldman D.E., Bliwise N.G. et al. Risk factor for sleep disordered breathing in heterogeneous geriatric populations. J Am Geriatr Society 1987; 35 (2): 132-141.Foster G.E., Sanders M.H., Millman R. et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009; 32 (6): 1017-1039.Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Applied Physiol 2005; 99 (5): 1998-2007.Punjabi N.M., Shahar E., Redline S. et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521-530.Harsch I.A., Schahin S.P., Radespiel-Troger M. et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162.Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.Ip M.S.M., Lam B., Ng M.M.T. et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Critical Care Med 2002; 165 (5): 670-676.Meslier N., Gagnadoux F., Giraud P. et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.Somers V.K., Dyken M.E., Clary M.P., Abbound F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.Polotsky V.Y., Li J., Punjabi N.M. et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (1): 253-264.Botros N., Concato J., Mohsenin V. et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009; 122 (12): 1122-1127.Shin C., Kim J. et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 2005; 171: 287-291.Joo S., Lee S., Choi H.A. et al. Habitual snoring is associated with elevated hemoglobin A1c levels in non-obese middle-aged adults. J Sleep Res 2006; 15: 437-444.Peltier A.C., Consens F.B., Sheikh K. et al. Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med 2007; 8: 149-155.Kono M., Tatsumi K., Saibara T. et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392.Shaw J.E., Punjabi N.M., Wilding J.P. et al. Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81: 2-12.Oltmanns K.M., Gehring H., Rudolf S. et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169: 1231-1237.Cutler M.J., Swift N.M., Keller D.M. et al. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 2004; 96: 754-761.Mallon L., Broman J.E., Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28: 2762-2767.Yaggi K., Araujo A., McKinlay J. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29: 657-661.Tasali E., Ip M.S.M. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008; 5 (2): 207-217.Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.Coughlin S.R., Mawdsley L., Mugarza J.A. et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9): 735-741.Levy P., Bonsignore M.R., Eckel J. Sleep, sleepdisordered breathing andmetabolic consequences. Eur Respirat J 2009; 34 (1): 243-260.Makino S., Handa H., Suzukawa K. et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64: 12-19.Davies R., Turner R., Crosby J. et al. Plasma insulin and lipid levels in untreated obstructive sleep apnea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180-185.Gruber A., Horwood F., Sithole J. et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22.Sharma S.K., Kumpawat S., Goel A. et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007; 8: 12-17.Vgontzas A.N., Legro R.S., Bixler E.O. et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metabol 2001; 86 (2): 517-520.Theorell-Haglow J., Berne C., Janson C., Lindberg E. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008; 31: 1054-1060.Manzella D., Parillo M., Razzino T. et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Intern J Obes 2002; 26 (3): 370-375.Zhang L.Q., Yao W.Z., Wang Y.Z. et al. Relationship between obstructive sleep apnea/hypopnea syndrome and insulin resistance. Zhonghua Nei Ke Za Zhi 2006; 45 (3): 184-187.Leproult R., Copinschi G., Buxton O., Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997; 20 (10): 865-870.Strohl K.P. Diabetes and sleep apnea. Sleep 1996; 19: S225-S228.Ip M.S.M. Obstructive sleep apnoea, insulin resistance and sleepiness. Thorax 2008; 63: 939-940.Barcelo A., Barbe F., de la Pena M. et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946-950.Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. The Lancet 1999; 354 (9188): 1435-1439.Bopparaju S., Surani S. Sleep and Diabetes. Review article. Intern J Endocrinol 2010; 2010: 1-9.Kruszynska Y.T., Worrall D.S., Ofrecio J. et al. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 2002; 87 (1): 226-234.Nieto F.J., Young T.B., Lind B.K. et al. Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14): 1829-1836.Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15 (11): 2792-2800.Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.Zhan G., Serrano F., Fenik P. et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005; 172: 921-929.Furukawa S., Fujita T., Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.Laight D.W., Desai K.M., Gopaul N.K. et al. Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat. Br J Pharmacol 1999; 128: 269-271.